Compounds > thiazoles
Page last updated: 2024-08-21

thiazoles and Inflammatory Breast Cancer

thiazoles has been researched along with Inflammatory Breast Cancer in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Addo, KA; Chdid, L; Darr, DB; Devi, GR; Ehe, BK; Fleming, JM; Ingram, SM; Oladapo, HO; Roques, JR; Sauer, SJ; Strepay, D; Tarpley, M; Trinkler, M; Williams, KP1
Hirai, A; Ichiki, Y; Imanishi, N; Ishida, T; Kusanagi, K; Shinohara, S; Takeda, Y; Tanaka, F; Tashima, Y; Yoshimatsu, K1
Fant, ME; Glazer, RI; Kallakury, B; Kopelovich, L; Lu, J; Umans, R; Upadhyay, G; Xiao, J; Yin, Y; Yuan, H1

Other Studies

3 other study(ies) available for thiazoles and Inflammatory Breast Cancer

ArticleYear
Pharmacological targeting of GLI1 inhibits proliferation, tumor emboli formation and inĀ vivo tumor growth of inflammatory breast cancer cells.
    Cancer letters, 2017, 12-28, Volume: 411

    Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Female; Heterocyclic Compounds, 2-Ring; Humans; Inflammatory Breast Neoplasms; Mice; Mice, Inbred NOD; Mice, SCID; Molecular Targeted Therapy; Pyridines; Pyrimidines; Signal Transduction; Thiazoles; Xenograft Model Antitumor Assays; Zinc Finger Protein GLI1

2017
[A Case Report of Luminal A Male Inflammatory Breast Cancer that Was Difficult to Treat Because of Trousseau Syndrome].
    Journal of UOEH, 2019, Volume: 41, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms, Male; Cilostazol; Combined Modality Therapy; Cyclophosphamide; Docetaxel; Drug Combinations; Epirubicin; Factor Xa Inhibitors; Fatal Outcome; Fluorouracil; Humans; Inflammatory Breast Neoplasms; Male; Oxonic Acid; Pyridines; Radiotherapy, Intensity-Modulated; Skin Neoplasms; Syndrome; Tegafur; Thiazoles; Thrombophilia

2019
PPARĪ“ induces estrogen receptor-positive mammary neoplasia through an inflammatory and metabolic phenotype linked to mTOR activation.
    Cancer research, 2013, Jul-15, Volume: 73, Issue:14

    Topics: Animals; Carcinogenesis; Carcinoma, Ductal; Epithelium; Female; Gene Expression; Genes, erbB-2; Inflammation; Inflammatory Breast Neoplasms; Mammary Neoplasms, Experimental; Metabolomics; Mice; Mice, Transgenic; Phenotype; PPAR delta; Proto-Oncogene Proteins c-akt; Receptors, Estrogen; Receptors, Progesterone; Thiazoles; TOR Serine-Threonine Kinases

2013